Gabriela Gruia's Net Worth

$0

Estimate Recalculated Nov 1, 2024 09:24AM EST

Who is Gabriela Gruia?

Gabriela Gruia does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TScan Therapeutics, Inc., Molecular Templates, Inc., and Aprea Therapeutics, Inc..

SEC CIK

Gabriela Gruia's CIK is 0001860326

Past Insider Trading and Trends

2023 was Gabriela Gruia's most active year for acquiring shares with 4 total transactions. Gabriela Gruia's most active month to acquire stocks was the month of May. 2024 saw Gabriela Gruia paying a total of $0.00 for 47,500 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found

Molecular Templates, Inc. (MTEM) Snapshot price: $1.53

Interim Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 27
Form 4
—
0
—
—
0
Oct 27
Form 4
—
0
—
—
0
Aug 31
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 5
Form 3
—
0
—
—
0
No matching records found